AngioDynamics Q4 Loss Narrows In Line With Estimates

(RTTNews) - AngioDynamics, Inc. (ANGO) on Tuesday reported net loss of $19.5 million, or $0.51 per share, in the fourth quarter, narrower than $157.0 million, or $4.13 per share in the same quarter a year ago.

On an adjusted basis, loss was 0.1 million or break even per share, compared with loss of $2.1 million or $0.06 per share last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.0 per share.

Net sales for the quarter increased 31.7% year-over-year to 76.8 million. The consensus estimate was for $72.67 million.

Looking forward to the fiscal year 2022, the company sees sales to be in the range of $305 million to $310 million and adjusted earnings per share in the range of $0.00 to $0.05. analysts expect earnings of $0.07 per share on revenue of $297.9 million for the period.